Oruka Therapeutics (ORKA) EBIT Growth (3y) (2013 - 2024)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 32.96% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -29.67% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -50.81% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 13.47% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 16.35% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -12.10% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 55.96% |
| 10 | Oruka Therapeutics | 3.04 Bn | 2.65 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 13.58% |
| Mar 31, 2024 | 15.42% |
| Dec 31, 2023 | 32.31% |
| Sep 30, 2023 | 0.90% |
| Jun 30, 2023 | -14.63% |
| Mar 31, 2023 | -10.26% |
| Dec 31, 2022 | -6.60% |
| Sep 30, 2022 | -26.96% |
| Jun 30, 2022 | -28.76% |
| Mar 31, 2022 | -22.54% |
| Dec 31, 2021 | -46.64% |
| Sep 30, 2021 | -41.57% |
| Jun 30, 2021 | -30.91% |
| Mar 31, 2021 | -13.94% |
| Dec 31, 2020 | -38.04% |
| Sep 30, 2020 | 23.67% |
| Jun 30, 2020 | 38.23% |
| Mar 31, 2020 | 32.62% |
| Dec 31, 2019 | 33.22% |
| Sep 30, 2019 | 35.80% |
| Jun 30, 2019 | 27.40% |
| Mar 31, 2019 | 21.40% |
| Dec 31, 2018 | 52.57% |
| Sep 30, 2018 | 16.13% |
| Jun 30, 2018 | 7.44% |
| Mar 31, 2018 | -0.35% |
| Dec 31, 2017 | 72.27% |
| Sep 30, 2017 | -25.11% |
| Jun 30, 2017 | -32.20% |
| Mar 31, 2017 | -22.38% |
| Dec 31, 2016 | -13.35% |
| Sep 30, 2016 | -39.79% |
| Jun 30, 2016 | -48.72% |
| Mar 31, 2016 | -50.78% |
| Dec 31, 2015 | -53.45% |
| Sep 30, 2015 | -44.79% |
| Jun 30, 2015 | -33.41% |
| Mar 31, 2015 | -24.97% |
| Dec 31, 2014 | -16.92% |
| Sep 30, 2014 | -7.86% |
| Jun 30, 2014 | -12.19% |
| Mar 31, 2014 | -2.77% |
| Dec 31, 2013 | -7.81% |
| Sep 30, 2013 | 6.44% |
| Jun 30, 2013 | 19.18% |